Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125989293 | 12598929 | 3 | F | 20151220 | 20160901 | 20160726 | 20160904 | EXP | CA-BEH-2016071356 | CSL BEHRING | 84.00 | YR | E | M | Y | 0.00000 | 20160905 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125989293 | 12598929 | 1 | PS | BERIPLEX P/N | COAGULATION FACTOR IX HUMANCOAGULATION FACTOR VII HUMANCOAGULATION FACTOR X HUMANPROTEIN CPROTEIN S HUMANPROTHROMBIN | 1 | Unknown | 2000 IU, TOT | 9460111A | 125421 | 2000 | IU | INJECTION | ||||||
| 125989293 | 12598929 | 2 | SS | RED BLOOD CELLS, CONCENTRATED | HUMAN RED BLOOD CELL | 1 | Unknown | UNK | 0 | ||||||||||
| 125989293 | 12598929 | 3 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Intravenous (not otherwise specified) | 2.5 MG, TOT | 0 | 2.5 | MG | ||||||||
| 125989293 | 12598929 | 4 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Intravenous (not otherwise specified) | 2.5 MG, TOT | 0 | 2.5 | MG | ||||||||
| 125989293 | 12598929 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 75 MG, TOT | 0 | 75 | MG | ||||||||
| 125989293 | 12598929 | 6 | C | VANCOMYCIN | VANCOMYCIN | 1 | Oral | 125 MG, QID | 0 | 125 | MG | QID | |||||||
| 125989293 | 12598929 | 7 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 2.25 G, TID | 0 | 2.25 | G | TID | |||||||
| 125989293 | 12598929 | 8 | C | VITAMIN K | PHYTONADIONE | 1 | Intravenous (not otherwise specified) | 10 MG, TOT | 0 | 10 | MG | ||||||||
| 125989293 | 12598929 | 9 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, OD | 0 | 40 | MG | QD | |||||||
| 125989293 | 12598929 | 10 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Unknown | 500 ML, TOT | 0 | 500 | ML | ||||||||
| 125989293 | 12598929 | 11 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Unknown | 500 ML, TOT | 0 | 500 | ML |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125989293 | 12598929 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125989293 | 12598929 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125989293 | 12598929 | Dyspnoea | |
| 125989293 | 12598929 | Fluid overload | |
| 125989293 | 12598929 | Pleural effusion | |
| 125989293 | 12598929 | Rales | |
| 125989293 | 12598929 | Tachycardia | |
| 125989293 | 12598929 | Tachypnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125989293 | 12598929 | 1 | 20151220 | 0 | ||
| 125989293 | 12598929 | 2 | 20151220 | 20151220 | 0 | |
| 125989293 | 12598929 | 3 | 20151219 | 0 | ||
| 125989293 | 12598929 | 4 | 20151219 | 0 | ||
| 125989293 | 12598929 | 5 | 20151219 | 20151219 | 0 | |
| 125989293 | 12598929 | 6 | 20151219 | 0 | ||
| 125989293 | 12598929 | 7 | 20151219 | 0 | ||
| 125989293 | 12598929 | 8 | 20151219 | 0 | ||
| 125989293 | 12598929 | 10 | 20151219 | 0 |